Published on: August 26, 2019 at 07:00PM
Conditions: Diabetes Mellitus; Microvascular Coronary Artery Disease
Interventions: Drug: Ticagrelor; Drug: Clopidogrel
Sponsors: Region Skane; IHF GmbH - Institut für Herzinfarktforschung; Hippocrates Research; IRW consulting AB; AstraZeneca
Not yet recruiting
No comments:
Post a Comment